KR20100063090A - 알리스키렌 및 발사르탄의 생약 제제 - Google Patents
알리스키렌 및 발사르탄의 생약 제제 Download PDFInfo
- Publication number
- KR20100063090A KR20100063090A KR1020107006603A KR20107006603A KR20100063090A KR 20100063090 A KR20100063090 A KR 20100063090A KR 1020107006603 A KR1020107006603 A KR 1020107006603A KR 20107006603 A KR20107006603 A KR 20107006603A KR 20100063090 A KR20100063090 A KR 20100063090A
- Authority
- KR
- South Korea
- Prior art keywords
- component
- oral pharmaceutical
- fixed dose
- dose oral
- pharmaceutical combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97590907P | 2007-09-28 | 2007-09-28 | |
US97590107P | 2007-09-28 | 2007-09-28 | |
US97591907P | 2007-09-28 | 2007-09-28 | |
US97592507P | 2007-09-28 | 2007-09-28 | |
US60/975,919 | 2007-09-28 | ||
US60/975,925 | 2007-09-28 | ||
US60/975,909 | 2007-09-28 | ||
US60/975,901 | 2007-09-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20100063090A true KR20100063090A (ko) | 2010-06-10 |
Family
ID=40377183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020107006603A KR20100063090A (ko) | 2007-09-28 | 2008-09-24 | 알리스키렌 및 발사르탄의 생약 제제 |
Country Status (18)
Country | Link |
---|---|
US (1) | US20100209480A1 (ru) |
EP (1) | EP2205233A2 (ru) |
JP (1) | JP2010540547A (ru) |
KR (1) | KR20100063090A (ru) |
CN (1) | CN101808631A (ru) |
AR (1) | AR066168A1 (ru) |
AU (1) | AU2008309058B2 (ru) |
BR (1) | BRPI0817442A2 (ru) |
CA (1) | CA2698330A1 (ru) |
CL (1) | CL2008002829A1 (ru) |
CO (1) | CO6270217A2 (ru) |
EC (1) | ECSP10010052A (ru) |
MA (1) | MA31706B1 (ru) |
MX (1) | MX2010003441A (ru) |
PE (1) | PE20090654A1 (ru) |
TN (1) | TN2010000135A1 (ru) |
TW (1) | TW200924737A (ru) |
WO (1) | WO2009045795A2 (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5378384B2 (ja) * | 2007-09-28 | 2013-12-25 | ノバルティス アーゲー | 有機化合物のガレヌス製剤 |
AR073651A1 (es) * | 2008-09-24 | 2010-11-24 | Novartis Ag | Formulaciones galenicas de compuestos organicos |
US20120003308A1 (en) * | 2009-03-20 | 2012-01-05 | Sonali Bose | Pharmaceutical Composition Comprising Aliskiren |
JP2012520895A (ja) * | 2009-03-20 | 2012-09-10 | ノバルティス アーゲー | バルサルタンおよびアリスキレンの一定用量の組合せのガレヌス製剤 |
WO2011116115A1 (en) * | 2010-03-16 | 2011-09-22 | Novartis Ag | Aliskiren composition comprising a medium chain fatty acid, their process of manufacturing |
TR201002256A1 (tr) * | 2010-03-24 | 2011-10-21 | Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� | Stabil aliskiren formülasyonları |
CN101926793B (zh) * | 2010-08-05 | 2012-08-15 | 成都自豪药业有限公司 | 一种含替米沙坦和阿利吉伦的联合用药物及其制备方法 |
JP6267125B2 (ja) * | 2011-10-12 | 2018-01-24 | ダウ グローバル テクノロジーズ エルエルシー | 射出成型された剤形 |
EP2797580A2 (en) * | 2011-12-26 | 2014-11-05 | Novartis AG | Tablets and dry-coated agents |
CN103349652B (zh) * | 2013-05-11 | 2014-11-19 | 辽宁大学 | 含有四氢萘酰胺化合物或其可药用盐的高药物载荷片剂 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK469989D0 (da) * | 1989-09-22 | 1989-09-22 | Bukh Meditec | Farmaceutisk praeparat |
GB9613470D0 (en) * | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
US8168616B1 (en) * | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
US6669955B2 (en) * | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
PE20110121A1 (es) * | 2004-03-17 | 2011-02-28 | Novartis Ag | Composiciones farmaceuticas de aliskiren |
KR20070101843A (ko) * | 2004-10-08 | 2007-10-17 | 노파르티스 아게 | 확장기 기능장애 또는 확장기 심부전의 예방 또는 치료를위한 레닌 억제제의 용도 |
MY146830A (en) * | 2005-02-11 | 2012-09-28 | Novartis Ag | Combination of organic compounds |
CN101166523A (zh) * | 2005-04-27 | 2008-04-23 | 诺瓦提斯公司 | 治疗动脉粥样硬化的方法 |
-
2008
- 2008-09-24 WO PCT/US2008/077416 patent/WO2009045795A2/en active Application Filing
- 2008-09-24 PE PE2008001660A patent/PE20090654A1/es not_active Application Discontinuation
- 2008-09-24 AR ARP080104137A patent/AR066168A1/es not_active Application Discontinuation
- 2008-09-24 TW TW097136690A patent/TW200924737A/zh unknown
- 2008-09-24 EP EP08835022A patent/EP2205233A2/en not_active Withdrawn
- 2008-09-24 CN CN200880108860A patent/CN101808631A/zh active Pending
- 2008-09-24 AU AU2008309058A patent/AU2008309058B2/en not_active Ceased
- 2008-09-24 KR KR1020107006603A patent/KR20100063090A/ko not_active Application Discontinuation
- 2008-09-24 CA CA2698330A patent/CA2698330A1/en not_active Abandoned
- 2008-09-24 MX MX2010003441A patent/MX2010003441A/es not_active Application Discontinuation
- 2008-09-24 BR BRPI0817442-3A patent/BRPI0817442A2/pt not_active IP Right Cessation
- 2008-09-24 US US12/678,877 patent/US20100209480A1/en not_active Abandoned
- 2008-09-24 JP JP2010527091A patent/JP2010540547A/ja not_active Withdrawn
- 2008-09-24 CL CL2008002829A patent/CL2008002829A1/es unknown
-
2010
- 2010-03-17 MA MA32701A patent/MA31706B1/fr unknown
- 2010-03-26 EC EC2010010052A patent/ECSP10010052A/es unknown
- 2010-03-26 TN TNP2010000135A patent/TN2010000135A1/fr unknown
- 2010-04-19 CO CO10045487A patent/CO6270217A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP2205233A2 (en) | 2010-07-14 |
WO2009045795A2 (en) | 2009-04-09 |
AR066168A1 (es) | 2009-07-29 |
CO6270217A2 (es) | 2011-04-20 |
WO2009045795A3 (en) | 2009-07-16 |
TW200924737A (en) | 2009-06-16 |
AU2008309058A1 (en) | 2009-04-09 |
CA2698330A1 (en) | 2009-04-09 |
MX2010003441A (es) | 2010-04-21 |
AU2008309058B2 (en) | 2012-08-09 |
PE20090654A1 (es) | 2009-06-27 |
JP2010540547A (ja) | 2010-12-24 |
BRPI0817442A2 (pt) | 2015-06-16 |
US20100209480A1 (en) | 2010-08-19 |
CL2008002829A1 (es) | 2009-06-26 |
TN2010000135A1 (en) | 2011-09-26 |
MA31706B1 (fr) | 2010-09-01 |
CN101808631A (zh) | 2010-08-18 |
ECSP10010052A (es) | 2010-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20100063090A (ko) | 알리스키렌 및 발사르탄의 생약 제제 | |
JP4969586B2 (ja) | マルチプルユニット型徐放性経口製剤およびその製造方法 | |
KR101434906B1 (ko) | Nsaid 및 파라세타몰을 포함하는 조성물 | |
NO313124B1 (no) | Anvendelse av tramadol i fremstillingen av et medikament for behandling av smerte | |
SK8022002A3 (en) | Compressed tablet composition, process for the preparation thereof and its use | |
WO2019073477A1 (en) | PHARMACEUTICAL COMPOSITION OF APREMILAST WITH EXTENDED RELEASE | |
TW202337463A (zh) | 含藥物之立即釋放錠劑及形成該錠劑的方法 | |
JP2013253093A (ja) | ローラーコンパクターを使用した多微粒子の製造方法 | |
JP2015091830A (ja) | 有機化合物のガレヌス製剤 | |
KR20110063684A (ko) | 알리스키렌을 포함하는 생약 제형 및 용융 압출 과립화에 의한 그의 제조 방법 | |
TWI745598B (zh) | 非布司他控釋組合物及其製備方法 | |
EP3148513B1 (en) | Ceritinib formulation | |
WO2023213878A1 (en) | Solid tablet dosage form of ridinilazole | |
CN106511291A (zh) | 一种盐酸阿考替胺缓释片剂及其制备方法 | |
RU2541807C2 (ru) | Композиции с немедленным высвобождением лекарственного средства | |
CN116801867A (zh) | 利地利唑的固体片剂剂型 | |
EP2793853B1 (en) | Pharmaceutical formulations of flurbiprofen and glucosamin | |
CN104000821B (zh) | 含有替米沙坦和苯磺酸氨氯地平的口服双层片剂及其制备方法 | |
JP2021167306A (ja) | 崩壊性粒子の製造方法 | |
KR20100052253A (ko) | 발사르탄을 함유하는 고형 경구제형의 제조 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |